Cargando…
Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis
OBJECTIVE: Transcatheter arterial chemoembolization (TACE) and thalidomide have been used for treating primary hepatocellular carcinoma(HCC). This study aims to evaluate the clinical efficacy and safety of thalidomide and TACE in primary HCC. METHODS: Randomized controlled trials(RCTs) about efficac...
Autores principales: | Cao, De-Dong, Xu, Hui-Lin, Liu, Liang, Zheng, Yong-Fa, Gao, Si-Fa, Xu, Xi-Ming, Ge, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546534/ https://www.ncbi.nlm.nih.gov/pubmed/28402958 http://dx.doi.org/10.18632/oncotarget.16689 |
Ejemplares similares
-
Thalidomide Combined with Transcatheter Arterial Chemoembolization (TACE) for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and GR
por: Yang, Wenjie, et al.
Publicado: (2018) -
The Efficacy of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma in a Cohort of 487 Patients
por: Xie, Hui, et al.
Publicado: (2014) -
Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
por: Malik, Sara, et al.
Publicado: (2021) -
Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study
por: Han, Sang Hoon, et al.
Publicado: (2006) -
ShRNA knock‐down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization
por: Zhao, Zhong‐Wei, et al.
Publicado: (2017)